Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
2022 · Cancer Cell · 140 citations
https://doi.org/10.1016/j.ccell.2022.11.002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
453
Citations
6
h-index
6
i10-index
Gerlanda Vella is an academic researcher from VIB-KU Leuven Center for Cancer Biology. The author has contributed to research in topics: Immune cells in cancer & Single-cell and spatial transcriptomics & Angiogenesis and VEGF in Cancer. The author has an h-index of 6, co-authored 13 publications.
ORCID: 0000-0001-7175-3120Click to start Chat